» Articles » PMID: 25177209

Neuropsychological Tests for the Diagnosis of Alzheimer's Disease Dementia and Other Dementias: a Generic Protocol for Cross-sectional and Delayed-verification Studies

Overview
Publisher Wiley
Date 2014 Sep 2
PMID 25177209
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To determine the cross-sectional diagnostic accuracy of [index test] at various thresholds for ADD and other dementias [target condition] in [target population].ORTo determine the accuracy of [index test] at various thresholds for diagnosing ADD and other dementias [target condition] in [target population] after a follow-up period (delayed-verification studies).To investigate the heterogeneity of test accuracy in the included studies.To highlight the quality and quantity of research evidence available on the effectiveness of the index test in the target population.To identify gaps in the evidence and determine where further research is required.

Citing Articles

Diagnostic test accuracy of self-administered cognitive assessment tools for dementia.

Naeem F, McCleery J, Hietamies T, Ismail F, Clinton S, OMahony A Cochrane Database Syst Rev. 2024; 12:CD013725.

PMID: 39698927 PMC: 11656514. DOI: 10.1002/14651858.CD013725.pub2.


Identification of altered immune cell types and molecular mechanisms in Alzheimer's disease progression by single-cell RNA sequencing.

Lin H, Su L, Mao D, Yang G, Huang Q, Lan Y Front Aging Neurosci. 2024; 16:1477327.

PMID: 39610716 PMC: 11602448. DOI: 10.3389/fnagi.2024.1477327.


Correlation between neurofilament, HMGB1, MMP9, ds DNA blood levels and cognitive impairment in patients with neuropsychiatric systemic lupus erythematosus.

Ahmadzade A, Simani L, Roozbeh M, Farsad F, Sheibani M, Negaresh O Caspian J Intern Med. 2024; 15(1):58-65.

PMID: 38463908 PMC: 10921114. DOI: 10.22088/cjim.15.1.6.


Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) for the diagnosis of delirium in adults in critical care settings.

Miranda F, Gonzalez F, Plana M, Zamora J, Quinn T, Seron P Cochrane Database Syst Rev. 2023; 11:CD013126.

PMID: 37987526 PMC: 10661047. DOI: 10.1002/14651858.CD013126.pub2.


New horizons in evidence synthesis for older adults.

Cooper N, Germeni E, Freeman S, Jaiswal N, Nevill C, Sutton A Age Ageing. 2023; 52(11.

PMID: 37955937 PMC: 11576477. DOI: 10.1093/ageing/afad211.


References
1.
Leeflang M, Moons K, Reitsma J, Zwinderman A . Bias in sensitivity and specificity caused by data-driven selection of optimal cutoff values: mechanisms, magnitude, and solutions. Clin Chem. 2008; 54(4):729-37. DOI: 10.1373/clinchem.2007.096032. View

2.
Mirra S, HEYMAN A, McKeel D, SUMI S, Crain B, Brownlee L . The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 1991; 41(4):479-86. DOI: 10.1212/wnl.41.4.479. View

3.
Matthews F, Stephan B, McKeith I, Bond J, Brayne C . Two-year progression from mild cognitive impairment to dementia: to what extent do different definitions agree?. J Am Geriatr Soc. 2008; 56(8):1424-33. DOI: 10.1111/j.1532-5415.2008.01820.x. View

4.
Borson S, Scanlan J, BRUSH M, Vitaliano P, Dokmak A . The mini-cog: a cognitive 'vital signs' measure for dementia screening in multi-lingual elderly. Int J Geriatr Psychiatry. 2000; 15(11):1021-7. DOI: 10.1002/1099-1166(200011)15:11<1021::aid-gps234>3.0.co;2-6. View

5.
Birks J . Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev. 2006; (1):CD005593. PMC: 9006343. DOI: 10.1002/14651858.CD005593. View